Stock listing

Serina Therapeutics, Inc.

Selected listing: SER · AMEX · USD · US

Serina Therapeutics, Inc. (NYSE American: SER), Commercial Services. Latest release Sep 9, 2026: Serina Therapeutics Reports Cohort 1 Observations…

SER:AMEXUSDUSUpdated October 3, 2026

Ticker: NYSE American: SER
Asset type: Stock
Sector: Commercial Services
Industry: Miscellaneous Commercial Services
Exchange: NYSE American
Currency: USD

About Serina Therapeutics, Inc.

The company focuses on developing innovative therapeutic solutions. Investors can find more information about Serina Therapeutics and its market activities on its dedicated public company page.

Latest news from Serina Therapeutics, Inc.

Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2

September 9, 2026

Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit

April 7, 2026

Serina Therapeutics Announces NYSE American Acceptance of Continued Listing Compliance Plan

April 2, 2026

Serina Therapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights

March 25, 2026

Serina Therapeutics to Present at the 38th Annual Roth Conference

March 24, 2026

All Serina Therapeutics, Inc. news →

Research Serina Therapeutics, Inc.

Serina Therapeutics, Inc. company profile

View the public company page for Serina Therapeutics, Inc. on 6ix.

Serina Therapeutics, Inc. news

Read company news and market updates connected to Serina Therapeutics, Inc..

Serina Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Serina Therapeutics, Inc..